Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 39 holding rows worth $99,403,764.

Accession
0001104659-25-013432
Filer
CIK 1582844
Filed
2025-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 39 entries on the cover page, a total value of $99,403,764 stated on the cover page (in dollars after the unit check, H1), rows summing to $99,403,764 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OCULAR THERAPEUTIX INC67576A100COM1,111,071$9,488,546dollars as filed
INSMED INC COM PAR $.01457669307Stock104,800$7,235,392dollars as filed
Tourmaline Bio Inc89157D105Common Stock351,842$7,135,356dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock122,900$6,283,877dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock267,368$6,015,780dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN1,849,402$5,834,863dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW67,500$5,194,800dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock111,700$4,885,758dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR6,910$4,249,650dollars as filed
VAXCYTE INC COM92243G108Stock45,000$3,683,700dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock771,958$3,180,467dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR22,976$3,163,106dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN779,308$2,727,578dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK69,124$2,489,846dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock447,500$2,479,150dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM87,658$2,340,469dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS180,945$1,899,923dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y103CMN2,303,000$1,829,043dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM134,500$1,690,665dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock137,709$1,619,458dollars as filed
Mersana Therapeutics Inc59045L106Common Stock1,120,500$1,602,315dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK884,244$1,529,742dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK33,008$1,523,979dollars as filed
CIDARA THERAPEUTICS INC171757206COM NEW54,473$1,464,234dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK50,000$1,285,000dollars as filed
ZYMEWORKS INC98985Y108COM67,240$984,394dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM235,750$971,290dollars as filed
VERVE THERAPEUTICS INC92539P101COM160,200$903,528dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM21,000$883,470dollars as filed
Gilead Sciences,Inc.375558103COM9,150$845,186dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock10,743$823,881dollars as filed
SANGAMO THERAPEUTICS INC800677106COM740,000$754,800dollars as filed
THIRD HARMONIC BIO INC88427A107COM49,800$512,442dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM44,000$443,520dollars as filed
FORTE BIOSCIENCES INC34962G208COMMON STOCK18,139$411,937dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM74,307$397,542dollars as filed
CELCUITY INC15102K100COM25,000$327,250dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock16,400$290,936dollars as filed
NUVATION BIO INC67080N119WARR90,832$20,891dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-013432this filing2025-02-14acceptance time not in the bulk data set